BiotechTube
Home/Neurimmune/Christoph Hock, MD
CH

Christoph Hock, MD

CMO & Director, Co-Founder

Neurimmune

Therapeutic Areas

Alzheimer's DiseaseAmyotrophic Lateral SclerosisATTR CardiomyopathySpinal Cord InjurySystemic Amyloidosis

Neurimmune Pipeline

DrugIndicationPhase
Cliramitug (ALXN2220/NI006)ATTR Cardiomyopathy (ATTR-CM)Phase 3
AP-101Amyotrophic Lateral Sclerosis (ALS)Phase 1/2
NG004Spinal Cord InjuryPhase 1
NI101B3Alzheimer's DiseasePreclinical
NI009Systemic AmyloidosisPreclinical

Leadership Team at Neurimmune

RM
Roger M. Nitsch, MD
CEO & President, Co-Founder
View full Neurimmune profile